Nebivolol IP/USP/IH is a pharmaceutical compound known for its effectiveness in managing hypertension, utilizing its unique beta-adrenergic blocking properties. It is a trusted medication recommended by healthcare professionals for its proven safety and efficacy.
| Specification | Description |
|---|---|
| Drug Name | Nebivolol IP/USP/IH |
| Pharmacopeial Standard | United States Pharmacopeia (USP) |
| Chemical Formula | C22H25F2NO4 |
| Molecular Weight | 405.44 g/mol |
| Therapeutic Class | Beta-adrenergic blocker |
| Indication | Management of hypertension |
| Route of Administration | Oral |
| Half-Life | 10-12 hours |
| Bioavailability | 12% |
| Protein Binding | Approximately 98% |
| Metabolism | Hepatic metabolism via CYP2D6 |
| Excretion | Renal (approximately 38%) and fecal (approximately 44%) |
| Dosage Forms | Tablets (2.5 mg, 5 mg, 10 mg) |
| Storage | Store at controlled room temperature (20-25°C) |
| Shelf Life | 3 years |
| Manufacturer | Multiple pharmaceutical companies |
Copyright © 2023. All rights reserved. Design By Techno Mantra
Copyright © 2024 – All rights reserved. Design By Technomantra India / Technomantra Global / Technomantra us / Technomantra Canada Technomantra local / Technomantra Australia